News

Prime Medicine's Exciting Conference Participation Announced

Prime Medicine's Exciting Conference Participation Announced

Prime Medicine Announces Upcoming Conference Participation

Prime Medicine, Inc. (NASDAQ: PRME), a pioneering biotechnology company, has recently made an exciting announcement regarding its participation in several prestigious investor conferences. This initiative highlights the company’s commitment to engaging with the investment community and providing insights into its groundbreaking work in genetic therapies.

Key Conferences to Note

Citi's 2025 Biopharma Back to School Conference

The management team at Prime Medicine will be present for a fireside chat at Citi's 2025 Biopharma Back to School Conference. This event is scheduled for Tuesday, September 2, 2025, at 4:45 p.m. ET, taking place in a vibrant venue in Boston. This conference serves as a platform for discussing crucial developments in the biopharmaceutical sector.

Morgan Stanley's Annual Global Healthcare Conference

Following the Citi event, Prime Medicine will also partake in Morgan Stanley's 23rd Annual Global Healthcare Conference. A fireside chat is scheduled for Monday, September 8, 2025, at 1:05 p.m. ET in New York City. Here, executives will share insights about the company’s progress and future plans, making it a must-attend for investors.

Accessing Company Presentations

For those unable to attend in person, live audio webcasts of each presentation will be available. You can access them by visiting the "Events & Presentations" section on the Prime Medicine website. Replays will be provided for a period of 90 days, ensuring that investors and interested parties can stay informed about the company's latest developments.

About Prime Medicine

Prime Medicine is dedicated to developing a new era of genetic therapies that aim to address numerous genetic disorders. Utilizing the innovative Prime Editing platform, the company is committed to achieving precise and effective gene edits while ensuring minimal unintentional impacts on the DNA. This technology holds immense promise for treating a wide range of genetic conditions across various tissues and organs.

Research and Development Focus

The company is advancing a diverse portfolio of therapeutic programs focusing on liver diseases, lung disorders, and both immunology and oncology. Each program targets diseases with clear biological pathways, providing a strategic route for clinical development. As the company progresses, it aims to broaden its reach, exploring additional genetic disorders, cancers, infectious diseases, and even targeting risk factors in common diseases, potentially impacting millions.

Investor and Media Contacts

Gregory Dearborn
Prime Medicine
Phone: 857-209-0696
Email: gdearborn@primemedicine.com

Hannah Deresiewicz
Precision AQ
Phone: 212-362-1200
Email: hannah.deresiewicz@precisionaq.com

Frequently Asked Questions

What is Prime Medicine?

Prime Medicine, Inc. is a biotechnology firm focused on creating advanced gene editing therapies to treat various genetic conditions.

What are the key upcoming conferences for Prime Medicine?

Prime Medicine will participate in Citi's 2025 Biopharma Back to School Conference and Morgan Stanley's Annual Global Healthcare Conference.

How can I listen to the company presentations?

Live audio webcasts of each presentation will be available on the Prime Medicine website, along with replay access for 90 days post-event.

What is the Prime Editing platform?

The Prime Editing platform is an advanced gene editing technology that allows for precise modifications to DNA with minimal unintended changes, offering a new hope for various genetic disorders.

Who can I contact for more information about Prime Medicine?

For inquiries, you can contact Gregory Dearborn at Prime Medicine or Hannah Deresiewicz at Precision AQ via their provided emails.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Insurance Bad Faith: Navigating California's Rigorous Laws

Updated Category News Views 6

Understanding What Constitutes Bad Faith Insurance What does it really mean when an insurer acts in "bad faith"? Well, the legal standard doesn't leave much wiggle room in California. These aren't just bad outcomes; we're talking about conduct that defies what's reasonable under state law. Demián I. Oksenendler, a seasoned bad faith attorney, shed some light on this in a...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 0

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 0

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading
QuickFi Nabs Top Finovate Award for Fourth Time

Updated Category News Views 0

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Continue Reading
Havoc, CSBC Partner for Autonomous Maritime Future

Updated Category News Views 7

A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 0

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Moore Law Investigates Aardvark Therapeutics' Risks

Updated Category News Views 2

Moore Law Launches Probe Into Aardvark Therapeutics Nobody likes stumbling across bad news over their morning coffee, but sometimes the market loves to keep you on your toes. Now it's Aardvark Therapeutics (NASDAQ: AARD) in the headlines, and not how they'd like. This time, Moore Law PLLC is rolling up its sleeves to dig into potential misconduct by the company's top...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 5

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
High-Grade Copper Spurs Optimism for PolarX in Alaska

Updated Category News Views 0

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Continue Reading

Top 5 Most Recently Viewed Articles

Promoting Mental Wellness in Athletics: A Collaborative Effort

Updated Category News Views 403

Athlete Mental Health Week: A Collaborative Initiative The upcoming Athlete Mental Health Week (AMHW) is set to take place soon, bringing together several nonprofit organizations dedicated to improving mental health awareness among athletes. This year's participants include Hilinski's Hope Foundation, Athletes for Hope, the Kevin Love Fund, and the Sarah Shulze...

Continue Reading
Pulnovo Medical Secures New Funding to Boost Global Growth

Updated Category News Views 243

Pulnovo Medical Announces New Investment to Expand Global Reach Pulnovo Medical, a renowned pioneer in medical devices focused on pulmonary hypertension and heart failure, has secured a new investment from EQT Group, a prominent global private equity firm. This partnership symbolizes an exciting new chapter for the company, which continues to receive unwavering support...

Continue Reading
Exciting News: The New Racing Prodigy Series Takes Off This Year

Updated Category News Views 246

Racing Prodigy™ Launches Innovative Racing Series Racing Prodigy™ is set to shake up the motorsports world by introducing an exciting gaming-to-real-life racing series. This series not only redefines the way fans can interact with motorsports but also aims to increase accessibility in competitive racing. Transforming Passion into Reality The concept behind this...

Continue Reading
Mega Matrix's FlexTV Streams a New Sports Drama

Updated Category News Views 11

A Fresh Twist in Sports Dramas Drama, sports, and comeback stories are like peanut butter and jelly—each one complements the other perfectly. Now, Mega Matrix Inc. is jumping into the arena with their new short-drama series, From NBA Dropout to Tennis Ace, streaming on their platform, FlexTV. Throw aside any expectations of typical sports films because this one's not...

Continue Reading
EPAM Systems Achieves Top IT Vendor Status for 2025 in Europe

Updated Category News Views 441

EPAM Systems Recognized as a Leading IT Vendor in Europe EPAM Systems, Inc. (NYSE: EPAM), a prominent name in digital transformation services and product engineering, has achieved remarkable recognition as a top IT vendor in Europe for 2025. This accolade is particularly noteworthy as it marks the second consecutive year in which EPAM has earned this honor, as evidenced...

Continue Reading